Friday, July 10, 2026
🇺🇸 FDA

pharma · Head and Neck Neoplasms · Rheumatoid Arthritis

Chinese University of

Chinese University of Hong Kong

Chinese University of trial registry — 42 ClinicalTrials.gov studies with program phase, status, and indication context.

CN HQ
NMPA registrant Type
Company details
Status
Public
HQ
CN
Programs
42
Drugs
55
Patents
0
All projects Drug pipeline News & analysis
Intelligence · Clinical Trials

Chinese University of clinical trials

Registry index of 42 ClinicalTrials.gov studies linked to Chinese University of programs — each row shows trial ID, program name, phase, status, and indication.

Chinese University of trial registry — 42 ClinicalTrials.gov studies with program phase, status, and indication context.

Recent trial activity

8 updates

Latest clinical program signals indexed for Chinese University of.

  1. CSSN-6091-DaweiLiu — Approved

    Clinical update

  2. Jinling37ICUZCY — Phase 2

    Clinical update

  3. 115 — Approved

    Clinical update

  4. Western therapy — Unknown

    Clinical update

  5. Unified protocol for adolescents (UP-A) — Phase 3

    Clinical update

  6. Tissue Plasminogen Activator — Phase 3

    Clinical update

  7. Sodium valproate — Approved

    Clinical update

  8. rituximab — Phase 2

    Clinical update

Trial registry

42 studies

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.